1151.40 -21.50 (-1.83%)

27.68% Fall from 52W High

507.1K NSE+BSE Volume

NSE 30 May, 2025 2:35 PM (IST)

Estimates Beat
Aurobindo Pharma's Q4FY25 revenue grows 10.4% YoY, beats Forecaster estimates by 2.8% See details


Aurobindo Pharma Ltd. Earnings/Conference Calls

Aurobindo Pharma Ltd. earnings concalls and investor presentations

1243 Votes:
Buy 80.13%
Sell 13.84%
Hold 6.03%
BUY
SELL
HOLD